Association of IL1B polymorphism with left ventricular systolic dysfunction: A relation with the release of interleukin-1β in stress condition

Pharmacogenetics and Genomics

Volumn 21, Issue 9, 2011, Pages 579-586

  Guéant Rodriguez, Rosa Maria ^a,b   Juillière, Yves ^b   Battaglia Hsu, Shyue Fang ^a   Debard, Renée ^a   Gérard, Philippe ^a   Reyes, Pedro ^d   Danchin, Nicolas ^c   Guéant, Jean Louis ^a  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Cardiology National Institution Hospital   (Mexico)

Author keywords

heart failure; inflammation; interleukin 1 ; polymorphisms; stress

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CYTOKINE RELEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SALIVA LEVEL; STRESS; SYSTOLIC DYSFUNCTION;

EID: 80051783230     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283493a05     Document Type: Article

References (52)

1. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996;77:723-727. (Pubitemid 26116687)
2. Long CS. The role of interleukin-1 in the failing heart. Heart Fail Rev 2001;6:81-94.
3. Mauviel A, Qiu Chen Y, Dong W, Evans CH, Uitto J. Transcriptional interactions of transforming growth-factor-[beta] with pro-inflammatory cytokines. Curr Biol 1993;3:822-831. (Pubitemid 2024170)
4. Booz GW, Baker KM. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 1995;30:537-543.
5. Li YY, McTiernan CF, Feldman AM. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc Res 1999;42:162-172. (Pubitemid 29167081)
6. Hoffman M. Clinical immunology and serology a laboratory perspective. Philadelphia: Philadelphia FA Davis Company; 2003.
7. Castell JV, Gómez-Lechón MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988;232:347-350.
8. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 1998;856:1-11. (Pubitemid 28517331)
9. Satoh M, Nakamura M, Saitoh H, Satoh H, Maesawa C, Segawa I, et al. Tumor necrosis factor-{alpha}-converting enzyme and tumor necrosis factor-{alpha} in human dilated cardiomyopathy. Circulation 1999;99:3260-3265. (Pubitemid 29293436)
10. Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK, et al. Combination of tumor necrosis factor-{alpha} ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ Res 2005;97:380-390. (Pubitemid 41216143)
11. Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M. Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 2006;70:857-863. (Pubitemid 43979122)
12. El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, et al. Correction: the role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001;412:99. (Pubitemid 32851519)
13. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-{alpha} promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561-568. (Pubitemid 29380293)
14. Mwantembe O, Gaillard MC, Barkhuizen M, Pillay V, Berry SD, Dewar JB, et al. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals. Immunogenetics 2001;52:249-254. (Pubitemid 32142812)
15. Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res 2000;15:402-414. (Pubitemid 30134084)
16. Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, Ohlsson C, et al. Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab 2006;91:2749-2754. (Pubitemid 44026381)
17. Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 1999;189:1863-1874.
18. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-310.
19. Miettinen KH, Lassus J, Harjola VP, Siirila-Waris K, Melin J, Punnonen KR, et al. Prognostic role of pro-and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 2008;10:396-403.
20. Vadlamani L, Iyengar S. Tumor necrosis factor polymorphism in heart failure/cardiomyopathy. Congest Heart Fail 2004;10:289-292.
21. Tiret L, Mallet C, Poirier O, Nicaud V, Millaire A, Bouhour JB, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000;35:29-35. (Pubitemid 30061255)
22. Ridker PM. High-sensitivity c-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818. (Pubitemid 32291421)
23. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235.
24. *2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:1036-1038. (Pubitemid 38869621)
25. Gueant-Rodriguez RM, Gueant JL, Viola M, Tramoy D, Gaeta F, Romano A. Association of tumor necrosis factor-[alpha]-308G > A polymorphism with IgE-mediated allergy to betalactams in an Italian population. Pharmacogenomics J 2007;8:162-168. (Pubitemid 351418952)
26. Vamvakopoulos JE, Taylor CJ, Green C, McNeil K, Wallwork J, Goodman R, et al. Interleukin 1 and chronic rejection: possible genetic links in human heart allografts. Am J Transplant 2002;2:76-83. (Pubitemid 36306810)
27. Dugué B, Ilardo G, Aimone-Gastin I, Guéant J, Mouze-Amady M, Cnockaert J, et al. Cytokines in saliva: basal concentrations and the effect of high ambient heat (sauna). Stress Med 1996;12:193-197.
28. Ilardo C, Toniolo A, Aimone-Gastin I, Abdelmouttaleb I, Guéant JL, Desor D. Effects of psycho-physical stress (competitive rafting) on saliva interleukin-1 beta. Stress Health 2001;17:9-15. (Pubitemid 32266104)
29. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup JA. TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
30. Hasdai D, Scheinowitz M, Leibovitz E, Sclarovsky S, Eldar M, Barak V. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart 1996;76:24-28. (Pubitemid 26267134)
31. Guillen I, Blanes M, Gomez-Lechon MJ, Castell JV. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol Regul Integr Comp Physiol 1995;269:R229-R235.
32. Lagoo AS, George JF, Naftel DC, Griffin AK, Kirklin JK, Lagoo-Deenadayalan S, et al. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. J Heart Lung Transplant 1996;15:206-217. (Pubitemid 26135662)
33. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996;183:949-958. (Pubitemid 26113964)
34. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996;28:964-971. (Pubitemid 26348163)
35. Brown JM, White CW, Terada LS, Grosso MA, Shanley PF, Mulvin DW, et al. Interleukin 1 pretreatment decreases ischemia/reperfusion injury. Proc Natl Acad Sci USA 1990;87:5026-5030.
36. Maulik N, Engelman RM, Wei Z, Lu D, Rousou JA, Das DK. Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Circulation 1993;88:II387-II394.
37. O'Neill L, Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 1998;63:650-657. (Pubitemid 28274824)
38. Kacimi R, Long CS, Karliner JS. Chronic hypoxia modulates the interleukin-1 stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation 1997;96:1937-1943. (Pubitemid 27400756)
39. Kacimi R, Karliner JS, Koudssi F, Long CS. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ Res 1998;82:576-586. (Pubitemid 28129028)
40. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-[kappa]B and [beta]-amyloid precursor protein. Cell 2002;110:55-67. (Pubitemid 34874606)
41. Kawamura N, Kubota T, Kawano S, Monden Y, Feldman AM, Tsutsui H, et al. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy. Cardiovasc Res 2005;66:520-529. (Pubitemid 40725764)
42. Kawano S, Kubota T, Monden Y, Tsutsumi T, Inoue T, Kawamura N, et al. Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 2006;291:H1337-H1344. (Pubitemid 44343679)
43. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, et al. Tumor necrosis factor-{alpha} and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-711.
44. Parthenakis FI, Patrianakos A, Prassopoulos V, Papadimitriou E, Nikitovic D, Karkavitsas NS, et al. Relation of cardiac sympathetic innervation to proinflammatory cytokine levels in patients with heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2003;91:1190-1194. (Pubitemid 36561382)
45. Amosova EN, Shpak YV, Nedozhdij AV, Produsevich LV. Proinflammatory cytokine levels in patients with diastolic heart failure. Kardiol Pol 2004;61:17-20. (Pubitemid 38987655)
46. Sato H, Watanabe A, Tanaka T, Koitabashi N, Arai M, Kurabayashi M, et al. Regulation of the human tumor necrosis factor-[alpha] promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cisacting promoter sequences and transcriptional factors. J Mol Cell Cardiol 2003;35:1197-1205. (Pubitemid 37163528)
47. Massion PB, Pelat M, Belge C, Balligand JL. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A Mol Integr Physiol 2005;142:144-150. (Pubitemid 41443574)
48. Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA, et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004;110:3221-3228. (Pubitemid 39525069)
49. Janczewski AM, Kadokami T, Lemster B, Frye CS, McTiernan CF, Feldman AM. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol 2003;284:H960-H969. (Pubitemid 36228245)
50. Miller VM, Redfield MM, McConnell JP. Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk. Curr Vasc Pharmacol 2007;5:15-25.
51. Lin RC, Morris BJ. Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. Am J Med Genet 2002;107:311-316. (Pubitemid 34062084)
52. Andrzejczak D, Górska D, Czarnecka E. Influence of amlodipine and atenolol on lipopolysaccharide (LPS)-induced serum concentrations of TNF-alpha, IL-1, IL-6 in spontaneously hypertensive rats (SHR). Pharmacol Rep 2006;58:711-719. (Pubitemid 44741690)